|
SMU1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.6807999981292E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.52900000438549E-08 |
| Normal-vs-Stage2 |
2.93130000050823E-07 |
| Normal-vs-Stage3 |
8.26670000000362E-05 |
| Normal-vs-Stage4 |
1.627080E-04 |
| Stage1-vs-Stage2 |
5.247200E-01 |
| Stage1-vs-Stage3 |
8.528000E-01 |
| Stage1-vs-Stage4 |
8.818200E-01 |
| Stage2-vs-Stage3 |
7.866000E-01 |
| Stage2-vs-Stage4 |
8.270400E-01 |
| Stage3-vs-Stage4 |
9.752000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.43439998662376E-09 |
| Normal-vs-AfricanAmerican |
2.34889999994881E-06 |
| Normal-vs-Asian |
2.157100E-04 |
| Caucasian-vs-AfricanAmerican |
4.808400E-01 |
| Caucasian-vs-Asian |
5.550200E-01 |
| AfricanAmerican-vs-Asian |
3.275200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.12739945051987E-10 |
| Normal-vs-Female |
1.323280E-03 |
| Male-vs-Female |
3.649700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.5942000000011E-05 |
| Normal-vs-Extreme_Weight |
4.53909998476831E-09 |
| Normal-vs-Obese |
1.607720E-04 |
| Normal-vs-Extreme_Obese |
7.864200E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.324000E-01 |
| Normal_Weight-vs-Obese |
5.852200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.356400E-01 |
| Extreme_Weight-vs-Obese |
1.419420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.710600E-01 |
| Obese-vs-Extreme_Obese |
4.532200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.021600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.57650000001775E-06 |
| Normal-vs-Age(61-80Yrs) |
3.1197000538441E-10 |
| Normal-vs-Age(81-100Yrs) |
2.162000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.503200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.241830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.994820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.824000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.620400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.432600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.43010000403154E-08 |
| Normal-VS-Type2 PRCC |
1.62070001863412E-09 |
| Normal-VS-KIRP CIMP |
5.447200E-01 |
| Normal-VS-Unclassified PRCC |
2.761800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.865900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.395900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.408400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.663800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.950000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.372450E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44359993245769E-10 |
| Normal-vs-N1 |
1.761610E-03 |
| Normal-vs-N2 |
8.98369999946524E-07 |
| N0-vs-N1 |
3.627200E-01 |
| N0-vs-N2 |
1.274980E-01 |
| N1-vs-N2 |
1.589240E-01 |
|
|
